The early appearance of FcfRI during cell differentiation may be important for these cells to respond to IgE-mediated stimuli before granulation. The physiologic role of FcERI could be to mediate lymphokine production (IL-3, IL-, IL-6, and granulocyte/macrophage colony-stimulating factor) without inducing cellular degranulation. (J. Clin. Invest. 1990.
Introduction
The high-affinity receptor for IgE is found exclusively on the surface of mast cells and basophils (1) . The binding ofIgE to its receptor does not produce any apparent signal. Binding of multivalent antigens, however, to receptor-bound IgE aggregates the complexes on the cell surface, and the consequent aggregation of receptors induces degranulation of the cell and the release and generation of mediators of the allergic reaction (1) .
The high-affinity receptor for IgE (FcERI) is a complex of noncovalently attached subunits. It is a tetramere of one IgEbinding a chain (2, 3) , one fi chain (4, 5) , and two identical disulfide-linked y chains (6, 7) . Complementary DNA clones for the rat a (8, 9) , , (10) , and y ( 11) and for the human a (9, 12) have been isolated. We have found recently that the requirements of the human and rodent receptor to reach the cell surface are different, at least in transfected cells (1 1, 13) . Cotransfection of the a, S, and -y genes is necessary to induce sufficient expression of the rodent receptor (1 1), while transfection of the a and y genes seems sufficient for efficient expression of the human receptor (13) .
Nothing is known, however, about the relationship between FcERI expression and basophil and mast cell differentiation. For this reason, we have analyzed the temporal expression of FcERI in both human and mouse IL-3-dependent bone marrow cultures. It is known that when bone marrow cells are cultured in vitro in the absence of exogenous growth factors, the cells fail to differentiate and lose viability; however, in the presence of IL-3, proliferation proceeds rapidly and a substantial number of cells undergo morphological changes to adopt the phenotypic characteristics of mast cells in murine or basophils in human bone marrow cultures (14) (15) (16) (17) (18) . In this paper, we report that transcripts for the subunits of the IgE receptor and subsequently surface expression of FcERI appear at an early stage of differentiation in cultures destined to develop significant numbers of mouse mast cells or human basophils.
Methods
Materials. The following were purchased: RPMI 1640, Hepes (Biofluids, Inc., Rockville, MD), penicillin/streptomycin, nonessential amino acids, L-glutamine, sodium pyruvate (Flow Laboratories, Inc., McLean, VA), and FCS (HyClone Laboratories, Logan, UT).
Mouse bone marrow cultures. 6-10-wk-old BALB/c mice were killed by CO2 asphyxiation and bone marrow aseptically flushed from femurs into RPMI-1640 medium containing 4 mM L-glutamine, 5 X l0-5 M 2-mercaptoethanol, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 gg/ml streptomycin, and 0.1 mM nonessential amino acids (complete 1640). The cell suspension was then centrifuged at 400 g for 10 min, resuspended in complete 1640 four times, and finally resuspended in 75-cm2 tissue culture flasks at a density of 1 X 105 cells/ml in complete RPMI containing 10% vol/vol FCS. Flasks were then incubated at 370C in a 5% CO2 humidified atmosphere. Purified murine IL-3 (a kind gift ofDr. James Ihle, St. Jude's Children Research Hospital, Memphis, TN) was added to a final concentration of 20 U/ml. Cells were passed at weekly intervals to achieve a final concentration of 1 X IO' cells/ml at the time of feeding.
Mouse bone marrow colony-forming units were determined in a solid phase agarose system in which a feeder layer of agarose was overlaid with a cell layer in six-well plates (19) . The feeder layer in each well was composed of 1.25 ml ofcomplete RPMI 1640 medium, 0.375 ml 2X concentrated RPMI 1640, 0.5 ml FCS, and 0.375 ml of a 3.3% (wt/vol) stock agarose solution in distilled water. IL-3 was added to complete 1640 to give a final concentration of 100 U/ml. The agarose was allowed to equilibrate at 370C in 5% CO2 for I h before use. The cell layer in each well was composed of 0.36 ml of complete RPMI-1640, 0.18 ml of distilled water, 0.18 ml of FCS, and 0.18 ml of a 0.9% (wt/vol) stock agarose solution in distilled water and 0.1 ml of complete RPMI 1640 containing I X I0 bone marrow cells. Colonies were examined at weekly intervals by transferring individual colonies to glass slides by means of a pasteur pipette. The cells were then mashed gently onto the slide with a coverslip before staining.
Human bone marrow cultures. Human marrow was obtained from bone marrow aspirates of patients undergoing evaluation for mastocytosis, after informed consent. Bone marrow cells were cultured with human recombinant IL-3 (rIL-3)' (Genzyme Corp., Boston, MA) as described previously (19) . Briefly, cells were diluted 1:6 in complete RPMI 1640, layered over Ficoll-Paque, and centrifuged at 800 g for 20 min. The mononuclear cell layer was harvested, centrifuged at 400 g for 10 min, and resuspended in complete 1640 containing 1% FCS four times, and the cells finally resuspended in complete RPMI containing 10% FCS at a concentration of 5 X 105 cells/ml. Cells were then placed over a soft agarose culture in an interphase culture system using a single layer of agarose prepared in six-well plates (19) . 2 X 105 cells were resuspended in 400 AI of complete 1640 with 10% FCS and 100 U/ml of human recombinant IL3 and layered over agarose in each well. The agarose layer in each well consisted of 2.5 ml composed of 1.25 ml of complete RPMI 1640 medium, 0.375 ml 2X concentrated RPMI 1640,0.5 ml FCS, and 0.375 ml ofa 3.3% (wt/vol) stock agarose solution in distilled water. rIL-3 was added to complete 1640 to give a final concentration of 100 U/ml. The agarose was allowed to equilibrate at 370C in 5% CO2 for 1 h before use. Cells within each agarosecontaining well were fed weekly by removing 200 Al ofthe fluid over the agarose and replacing it with complete 1640 containing 10% FCS and appropriate concentrations of human IL-3. Cells were harvested by gently pipetting culture media several times over the agarose surface. Aliquots of cells were removed at weekly intervals for cell counts, histochemistry, and histamine determinations.
Human basophil isolation. Basophils were isolated from venous blood after leukopheresis of 2 liters of blood (NIH blood bank) by single step isopycnic banding on Percoll as described (20) . Briefly, 4 ml of human polymorphonuclear leukocytes were layered onto discontinuous Percoll gradients made from solutions with densities of 1.088, 1.079, and 1.070 g/ml. Final adjustment of the solution was facilitated by measurement of the refractive index. The refractive index of the solutions was measured at 22°C with a refractometer (Bausch & Lomb Inc., Rochester, NY). After centrifugation at 700 g for 25 min at 22°C, the majority ofthe basophils were found in a band between the layered solutions having densities of 1.070 and 1.079. Basophil purity ranged from 5 to 15%. Basophil yields from each leukopheresis pack were 1.5±0.4 X 106 cells.
Histochemical stains. Cultured cells were spun onto glass slides in a cytocentrifuge (Shandon Southern Instruments Inc., Sewickley, PA), allowed to air dry, and stained with Wright-Giemsa on an Ames Hematek automated slide stainer (Miles Laboratories Inc., Naperville, IL). Other slides were stained with acid toluidine blue (21) .
Histamine assay. Aliquots of cultured cells were counted, centrifuged at 800 g for 10 min, and resuspended in phosphate buffered saline (pH 7.4), and placed in a water bath at 100°C for 10 min. Samples were then analyzed for histamine content using an immunoassay that employs monoclonal antibodies raised against acylated histamine (22) . Histamine in the sample was acylated using succinyl glycinamide N-hydroxysuccinimide ester which was supplied with the antibody in a kit (Amac Inc., Westbrook, ME).
Flow cytometry and cell sorting. Cell sorting was performed on an Epics 753 (Coulter Electronics Inc., Hialeah, FL) with an Argon laser (Coherent Inc., Palo Alto, CA) tuned to 488 nm, wavelength 300 mW. A 530/30 bandpass optical filter was used to screen the FITC emission. Multiparameter data acquisition and display system software (Coulter Electronics Inc.) and a four-decade logarithmic amplifier were used for 1. Abbreviation used in this paper: rlL-3, recombinant IL-3. statistical analysis and the data displays. Cells were kept at 4VC during sorting with the instrument's cooling system. To evaluate the expression of FcERI receptors on the cell surface of mouse and human bone marrow cells, the cells were centrifuged at 800 g for 10 min and resuspended in HBSS without calcium or magnesium or phenol red, containing 0. I sodium azide and 0.2% bovine serum albumin. 4 Northern blot analysis. Total RNA was isolated by the guanidine isothiocyanate procedure (25) , followed by cesium chloride centrifugation (26). 5 (Fig. 1) , the fluorescent intensity and the size ofthe cells increased remarkably from 0 to 3 wk. The fluorescence could be completely quenched by preincubation of the cells with nonfluoresceinated IgE. In human bone marrow cultures (Fig. 2) , the increase in fluorescence over 3 wk was much less dramatic than in mouse bone marrow cultures, although the cell size also increased. Nevertheless, there was a slight increase in fluorescence better seen at 3 wk which could also be quenched with nonfluoresceinated IgE.
We next examined the appearance of mast cells and basophils in cultures of either murine or human bone marrow and correlated these findings with the percentage of FcERI-positive cells identified in Fig. 1 . As can be seen, the number of FcERIpositive cells was 75% at 1 wk while the number of identifiable mast cells was 25% (Fig. 3 a) , suggesting that the appearance of FcERI preceded the maturation ofthe mast cells themselves. In human bone marrow cultures, however, the number of basophils identified consistently exceeded the number of FcERIpositive cells identified by FACS analysis (Fig. 3 b) . Enrichment creased in number (Fig. 3 a) ( 19) and, more recently, by cell-surface markers (28) .
In the present study, the number of basophils identified mor-?O -~~20 " 2 phologically rose to -25.0% at 3 wk (Fig. 3 b) (Fig. 4 a) (Fig. 4 b) , and 0.75 kb (Fig. 4 c) for the a, 3, and Sy subunits, ed as mean±SEM for four exrespectively. There was a marked increase with time of the mRNA for each of the subunits (Fig. 4, top panels) . To show that equivalent amounts of RNA were loaded in each lane, the same filters were rehybridized with a f-actin probe (Fig. 4 (Fig. 6 a) , which corresponds to the size of staining with FITC-conjumRNA specific for rat -y (11) . each lane was again assessed by using a (.i-actin probe (Fig. 6, a  and b, bottom panels) . There was again an increase in mRNA for the a and y subunits (Fig. 6, a and b, top panels) shown by densitometry in Fig. 7 .
The fractional enrichments in mRNA for the a subunit and in basophil number appear similar (compare Figs. 6 b and 7 with Fig. 3 b) . The situation seems different for the y subunit. This may be explained by our recent observation that -y subunits are associated with one Fcy receptor from macrophages. In human IL-3 cultures, macrophages represent an important population (more than in mouse IL-3 cultures) which decreases over time. Therefore, it is likely that the amount of mRNA observed in the total population of cells results from two components: the increase in FcERI expression in basophils, and the decrease in Fcy receptor expression in macrophages.
Expression ofFcERI in human peripheral blood basophils. To verify that mature human peripheral blood basophils also express FcERI mRNA, poly (A+) RNA isolated from human peripheral blood basophils was hybridized with the cDNA probes specific for the rat y subunit and the human a subunit of FcERI. Northern blot analysis revealed mRNA species of 0.75 and 1.1 kb for the y and a subunits, respectively (Fig. 6 c) (Fig. 3  a) . By contrast, human bone marrow cells under similar conditions differentiate into basophils, (although a few mast cells can be observed [ 19] ), and the enrichment in human basophils is -25% over a period of 3 wk (Fig. 3 b) .
One common feature, however, between mouse and human IL-3 cultures is the parallelism between cell differentiation (in mast cells and basophils, respectively) and the enrichment in mRNA for the a subunit of FcERI (Figs. 3, 5, and  7) . Transcripts for the subunits of FcERI appear early in the process of differentiation and continue to increase over the 3 wk of culture. Because the y subunit is also associated with Fc-y receptors from macrophages, transcripts for the a subunit appear to be a better marker of mast cell and basophil differentiation (see Results).
Posttranscriptional events, however, appear to be different in mouse mast cells and human basophils. Mouse cells expressing FcERI on their surface appear in the culture before these cells could be recognized as mast cells by staining criteria. This was particularly obvious after 1 wk of culture (Fig. 3  a) . A population of receptor-positive cells selected by FACS sorting clearly contained undifferentiated cells. Interestingly, the number of receptor-positive cells increased less during the second and third weeks of culture. During that period of time, the cells were recognized as mast cells in increasing numbers. In addition, these cells increased in size and expressed progressively more receptors on their surface as judged by the increase in cell fluorescence (Fig. 1) .
The progressive enrichment in cell-surface receptors appeared slower in human basophils, with more basophils than receptor-positive cells (Fig. 3 b) . This may not be true, however. The signal-to-noise ratio may 
